Can-Fite BioPharma Ltd.CANFNYSE
Loading
Debt to Equity Over TimeElevated
Percentile Rank93
3Y CAGR+30.4%
5Y CAGR-9.0%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+30.4%/yr
Annual compound
5Y CAGR
-9.0%/yr
Recent acceleration
Percentile
P93
Near historical high
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.02 | +198.6% |
| 2023 | 0.01 | -53.8% |
| 2022 | 0.01 | +60.8% |
| 2021 | 0.01 | -21.8% |
| 2020 | 0.01 | -64.1% |
| 2019 | 0.03 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |
| 2015 | 0.00 | - |